27.82
前日終値:
$27.80
開ける:
$27.87
24時間の取引高:
5.39M
Relative Volume:
1.10
時価総額:
$14.27B
収益:
$17.28B
当期純損益:
$108.00M
株価収益率:
139.10
EPS:
0.2
ネットキャッシュフロー:
$391.00M
1週間 パフォーマンス:
-9.53%
1か月 パフォーマンス:
-19.57%
6か月 パフォーマンス:
-24.32%
1年 パフォーマンス:
-29.69%
Baxter International Inc Stock (BAX) Company Profile
名前
Baxter International Inc
セクター
電話
(847) 948-2000
住所
ONE BAXTER PKWY, DEERFIELD, IL
BAX を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
BAX
Baxter International Inc
|
27.82 | 14.27B | 17.28B | 108.00M | 391.00M | 0.20 |
![]()
ISRG
Intuitive Surgical Inc
|
481.34 | 172.45B | 8.35B | 2.32B | 1.30B | 6.41 |
![]()
BDX
Becton Dickinson Co
|
200.40 | 57.54B | 20.64B | 1.73B | 2.94B | 6.02 |
![]()
ALC
Alcon Inc
|
92.05 | 45.53B | 9.91B | 1.02B | 665.00M | 2.05 |
![]()
RMD
Resmed Inc
|
211.49 | 31.06B | 4.93B | 1.25B | 1.38B | 8.47 |
![]()
COO
The Cooper Companies, Inc.
|
78.23 | 15.58B | 3.90B | 392.30M | 288.10M | 1.95 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-02-26 | 再開されました | Goldman | Buy |
2025-02-24 | アップグレード | Argus | Hold → Buy |
2025-02-20 | 再開されました | Barclays | Overweight |
2024-07-15 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
2024-05-30 | 開始されました | Goldman | Neutral |
2024-05-10 | ダウングレード | TD Cowen | Buy → Hold |
2023-05-30 | 再開されました | Morgan Stanley | Equal-Weight |
2023-03-29 | 開始されました | UBS | Neutral |
2023-01-06 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
2023-01-05 | ダウングレード | Raymond James | Outperform → Mkt Perform |
2023-01-03 | ダウングレード | BofA Securities | Buy → Neutral |
2022-12-19 | ダウングレード | JP Morgan | Overweight → Neutral |
2022-12-15 | ダウングレード | Deutsche Bank | Buy → Hold |
2022-12-12 | ダウングレード | Citigroup | Buy → Neutral |
2022-10-18 | 開始されました | Barclays | Overweight |
2022-10-12 | 開始されました | Jefferies | Hold |
2022-06-24 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
2022-04-04 | ダウングレード | Goldman | Neutral → Sell |
2022-03-02 | 再開されました | BofA Securities | Buy |
2022-02-18 | 繰り返されました | KeyBanc Capital Markets | Overweight |
2022-02-18 | 繰り返されました | Morgan Stanley | Overweight |
2022-02-18 | 繰り返されました | Raymond James | Outperform |
2022-02-18 | 繰り返されました | Stifel | Buy |
2022-02-18 | 繰り返されました | UBS | Neutral |
2022-02-18 | 繰り返されました | Wells Fargo | Overweight |
2022-02-11 | 開始されました | Goldman | Neutral |
2022-01-07 | 再開されました | Citigroup | Buy |
2022-01-07 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
2021-09-13 | アップグレード | Cowen | Market Perform → Outperform |
2021-09-03 | アップグレード | Barclays | Equal Weight → Overweight |
2021-05-25 | 開始されました | Barclays | Equal Weight |
2021-01-29 | ダウングレード | Piper Sandler | Overweight → Neutral |
2021-01-06 | ダウングレード | UBS | Buy → Neutral |
2020-12-15 | ダウングレード | Goldman | Buy → Neutral |
2020-10-01 | アップグレード | Citigroup | Neutral → Buy |
2020-09-04 | ダウングレード | Argus | Buy → Hold |
2020-06-24 | 開始されました | Oppenheimer | Outperform |
2020-03-19 | アップグレード | Stifel | Hold → Buy |
2020-03-18 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
2020-03-05 | 開始されました | Citigroup | Neutral |
2020-02-13 | 開始されました | Goldman | Buy |
2020-01-02 | アップグレード | Evercore ISI | In-line → Outperform |
2019-12-17 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
2019-06-26 | 開始されました | KeyBanc Capital Markets | Sector Weight |
2019-04-08 | ダウングレード | Evercore ISI | Outperform → In-line |
2019-01-02 | アップグレード | Citigroup | Neutral → Buy |
2019-01-02 | アップグレード | Morgan Stanley | Underweight → Overweight |
2018-11-02 | アップグレード | Argus | Hold → Buy |
2018-10-16 | 開始されました | Barclays | Underweight |
2018-05-17 | 再開されました | Piper Jaffray | Overweight |
2018-02-06 | 繰り返されました | Citigroup | Neutral |
2018-01-03 | 開始されました | Evercore ISI | Outperform |
2018-01-03 | アップグレード | Raymond James | Mkt Perform → Outperform |
すべてを表示
Baxter International Inc (BAX) 最新ニュース
Baxter International Inc. (NYSE:BAX) Shares Acquired by Jaffetilchin Investment Partners LLC - MarketBeat
Baxter to Host First-Quarter 2025 Financial Results Conference C - GuruFocus
Baxter to Host First-Quarter 2025 Financial Results Conference Call for Investors - The Joplin Globe
Latest Trends in Adhesion Barrier Market: 2024 to 2031 | Baxter - openPR.com
LSV Asset Management Has $159.96 Million Stake in Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter International (NYSE:BAX) Reaches New 1-Year LowShould You Sell? - MarketBeat
BAX Stock Declines Despite Latest Product Launch Boosting Patient Care - TradingView
Baxter International (BAX) Q3 2024 Earnings Call Transcript - Fortune
Baxter International (NYSE:BAX) Sets New 12-Month LowHere's Why - MarketBeat
Baxter International Inc. (NYSE:BAX) Position Raised by Russell Investments Group Ltd. - MarketBeat
Baxter International Enters Oversold Territory (BAX) - Nasdaq
Baxter Launches New Room Temperature Hemopatch Sealing Hemostat for Rapid and Convenient Application During Surgery - PharmiWeb.com
Baxter Launches New Room Temperature Hemopatch Sealing Hemostat - GuruFocus
Hurricane Helene impact on Baxter to further limit IV fluid supply, HHS says - AOL.com
Cullen Capital Management LLC Decreases Holdings in Baxter International Inc. (NYSE:BAX) - MarketBeat
Global Prefilled Syringes Market to Cross USD 28 Billion by 2032 | DelveInsight - GlobeNewswire Inc.
Breakthrough: Baxter's Enhanced Hemopatch Eliminates Surgery Prep Time with Room-Temperature Storage - Stock Titan
Geode Capital Management LLC Buys 290,279 Shares of Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch
Wound Care Market to Witness Remarkable Growth with 3M, Baxter, - openPR.com
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Shareholders of Baxter International Inc.(BAX) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
Artificial Kidney Market to See Revolutionary Growth | Baxter - openPR.com
Baxter International Inc (BAX) Shares Down 3.27% on Apr 7 - GuruFocus
Citigroup Adjusts Baxter International Price Target to $35 From $37, Maintains Neutral Rating - MarketScreener
Baxter stock touches 52-week low at $28.22 amid market challenges - Investing.com Australia
Baxter stock touches 52-week low at $28.22 amid market challenges By Investing.com - Investing.com South Africa
Intravenous Solutions Market Is Booming Worldwide | Baxter - openPR.com
Allstate Corp Makes New $450,000 Investment in Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter International (NYSE:BAX) CEO Change as Stock Dips 2% Last Quarter - Yahoo Finance
Baxter International Inc. (NYSE:BAX) Short Interest Update - MarketBeat
Healthcare: Policy Uncertainty Is Countered by Interest in Defensive Stocks - Morningstar
US hospitals strained by IV fluid supply limits after Helene hit production site - AOL.com
Evercore ISI Adjusts Baxter International Price Target to $45 From $44, Maintains Outperform Rating - MarketScreener
Baxter International Inc. (NYSE:BAX) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Baxter CEO pay surged before his departure — along with the median employee’s wage - Medical Design & Outsourcing
Is Baxter International Inc. (BAX) the Most Undervalued Healthcare Stock to Buy According to Analysts? - Insider Monkey
Baxter International (NYSE:BAX) investors are sitting on a loss of 55% if they invested five years ago - simplywall.st
Baxter International Inc (BAX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):